Abstract
Pharmacogenetic prediction and mechanistic elucidation of individual variations of drug response is important for facilitating the development of personalized medicines and optimum therapeutic dosages. One of the keys to pharmacogenetic studies is the knowledge about proteins responsible for the absorption, distribution, metabolism and excretion (ADME) of drugs. This article describes the web-resources of ADME-associated proteins, assesses the usefulness of the relevant information for facilitating pharmacogenetic prediction of drug responses, and discusses computational methods that explore the relevant information for predicting individual variations of drug response from the polymorphisms of ADME-associated proteins.
Keywords: Carrier, drug design, drug development, drug discovery, drug metabolizing enzyme, drug target, ligand-binding protein, pharmacokinetics, pharmacogenomics, pharmacogenetics
Current Pharmacogenomics
Title: Information of ADME-Associated Proteins and Potential Application for Pharmacogenetic Prediction of Drug Responses
Volume: 4 Issue: 2
Author(s): C. J. Zheng, L. Y. Han, X. Chen, Z. W. Cao, J. Cui, H. H. Lin, H. L. Zhang, H. Li and Y. Z. Chen
Affiliation:
Keywords: Carrier, drug design, drug development, drug discovery, drug metabolizing enzyme, drug target, ligand-binding protein, pharmacokinetics, pharmacogenomics, pharmacogenetics
Abstract: Pharmacogenetic prediction and mechanistic elucidation of individual variations of drug response is important for facilitating the development of personalized medicines and optimum therapeutic dosages. One of the keys to pharmacogenetic studies is the knowledge about proteins responsible for the absorption, distribution, metabolism and excretion (ADME) of drugs. This article describes the web-resources of ADME-associated proteins, assesses the usefulness of the relevant information for facilitating pharmacogenetic prediction of drug responses, and discusses computational methods that explore the relevant information for predicting individual variations of drug response from the polymorphisms of ADME-associated proteins.
Export Options
About this article
Cite this article as:
Zheng J. C., Han Y. L., Chen X., Cao W. Z., Cui J., Lin H. H., Zhang L. H., Li H. and Chen Z. Y., Information of ADME-Associated Proteins and Potential Application for Pharmacogenetic Prediction of Drug Responses, Current Pharmacogenomics 2006; 4 (2) . https://dx.doi.org/10.2174/157016006776286819
DOI https://dx.doi.org/10.2174/157016006776286819 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Molecular Cytogenetics of Autism
Current Genomics Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
Current Psychopharmacology Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued) p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases
Central Nervous System Agents in Medicinal Chemistry The Effects of Creatine Supplementation and Physical Exercise on Traumatic Brain Injury
Mini-Reviews in Medicinal Chemistry Blood Pressure Reduction in the Primary and Secondary Prevention of Stroke
Current Vascular Pharmacology Therapeutic Approaches to Eradicate Latent HIV-1 in Resting CD4+ T Cells
Current Topics in Medicinal Chemistry Utilizing Delta Opioid Receptors and Peptides for Cytoprotection: Implications in Stroke and Other Neurological Disorders
CNS & Neurological Disorders - Drug Targets Multifaceted Individualities in Pharmacological Treatments of Obesity
Current Clinical Pharmacology Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design Clinical Pharmacokinetics of Retigabine/Ezogabine
Current Clinical Pharmacology Neuroprotection Against Ischemic / Hypoxic Brain Damage: Blockers of Ionotropic Glutamate Receptor and Voltage Sensitive Calcium Channels
Current Drug Targets MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Genetic Polymorphism of Organic Anion and Cation Transporters: Pharmacokinetic and Pharmacodynamic Consequences in Pharmacotherapy
Current Pharmacogenomics A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects
Current Drug Abuse Reviews Random Walks on Biomedical Networks
Current Proteomics Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5
Current Psychopharmacology New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research